Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis

NCT01873677 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

537

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: M518101
DRUG: Vehicle

Sponsor

Maruho North America Inc.